首页>Clinical and experimental metastasis>The tumor-initiating capacity of prostate circulating tumor cells examined through a unique CTC-derived eXplant (CDX) model
The tumor-initiating capacity of prostate circulating tumor cells examined through a unique CTC-derived eXplant (CDX) model